摘要
目的:观察奥扎格雷钠联合丹参酮ⅡA磺酸钠治疗急性脑梗死的疗效。方法:将急性脑梗死患者105例,随机分为治疗组(45例)和对照组(60例),两组均给予常规治疗,在此基础上,治疗组给予奥扎格雷钠和丹参酮ⅡA磺酸钠,对照组给予奥扎格雷钠,两组均以14d为1个疗程。治疗结束后进行神经功能缺损评分和疗效评价。结果:治疗组总有效率为93.33%,对照组为73.33%,两组比较,差异有统计学意义(P<0.05)。结论:奥扎格雷钠联合丹参酮ⅡA磺酸钠治疗急性脑梗死临床疗效显著。
Objective： To study the therapeutic effect of sodium ozagrel combined sodium tanshinone ⅡA silate in treating cerbral infarction. Methods： 105 acute cerebral infarction patients were randomly divided into treatment group（45 cases） and control group（60 cases）. Both two groups were given regular treatment, based on the treatment, the treatment group were given sodium ozagrel combined sodium tanshinone ⅡA silate, the control group were given sodium ozagrel, the two group each had a course of treatment of 2 weeks. In the end of the treatment, did neurologic impairment score and evaluated the curative effect. Results： The total effective rate of the treatment group was 93.33%, the control group was 73.33%, respectively. And the difference of the two groups was statistical significance（P0.05）. Conclusion： The curative effect of sodium ozagrel combined sodium tanshinone ⅡA silate in treating the acute cerebral infarction is significant.
出处
《中国当代医药》
2010年第20期51-52,55,共3页
China Modern Medicine
关键词
急性脑梗死
奥扎格雷钠
丹参酮ⅡA磺酸钠
Acute cerebral infarction
Sodium ozagrel
Sodium tanshinone Ⅱ A silate
